4//SEC Filing
Jones Aranthan II 4
Accession 0001209191-20-043998
CIK 0001347178other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 8:17 PM ET
Size
5.6 KB
Accession
0001209191-20-043998
Insider Transaction Report
Form 4
Jones Aranthan II
Chief Corp. Affairs Officer
Transactions
- Sale
Common Stock
2020-07-27$10.62/sh−7,313$77,631→ 82,687 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001785894
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 8:17 PM ET
- Size
- 5.6 KB